-
1
-
-
0021720326
-
Association between blood pressure and the rate of decline in renal function with age
-
LINDEMAN RD, TOBIN J, SHOCK NW: Association between blood pressure and the rate of decline in renal function with age. Kidney Int 26: 861, 1984.
-
(1984)
Kidney Int
, vol.26
, pp. 861
-
-
Lindeman, R.D.1
Tobin, J.2
Shock, N.W.3
-
2
-
-
0031755420
-
The aging kidney
-
RODRIGUEZ-PUYOL D: The aging kidney. Kidney Int 54: 2247, 1998.
-
(1998)
Kidney Int
, vol.54
, pp. 2247
-
-
Rodriguez-Puyol, D.1
-
4
-
-
0020657043
-
Hospital-acquired renal insufficiency: A prospective study
-
HOU SH, BUSHINSKY DA, WISH JB, ET AL: Hospital-acquired renal insufficiency: a prospective study. Am J Med 74: 243, 1983.
-
(1983)
Am J Med
, vol.74
, pp. 243
-
-
Hou, S.H.1
Bushinsky, D.A.2
Wish, J.B.3
-
6
-
-
0023636281
-
Risk factors and outcome of hospital-acquired acute renal failure: Clinical epidemiologic study
-
SHUSTERMAN N, STROM BL, MURRAY TG, ET AL: Risk factors and outcome of hospital-acquired acute renal failure: clinical epidemiologic study. Am J Med 83: 65, 1987.
-
(1987)
Am J Med
, vol.83
, pp. 65
-
-
Shusterman, N.1
Strom, B.L.2
Murray, T.G.3
-
7
-
-
0028009722
-
Association of preoperative risk factors with postoperative acute renal failure
-
NOVIS BK, ROIZEN MF, ARONSON S, ET AL: Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg 78: 143, 1994.
-
(1994)
Anesth Analg
, vol.78
, pp. 143
-
-
Novis, B.K.1
Roizen, M.F.2
Aronson, S.3
-
9
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification
-
NATIONAL KIDNEY FOUNDATION: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39 (suppl 1): S1, 2002.
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.1 SUPPL.
-
-
-
10
-
-
0028892748
-
Hyperkalemia in end-stage renal disease: Mechanisms and management
-
ALLON M: Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol 6: 1134, 1995.
-
(1995)
J Am Soc Nephrol
, vol.6
, pp. 1134
-
-
Allon, M.1
-
11
-
-
0026607973
-
Hyperphosphatemia: Its consequences and treatment in chronic renal failure
-
DELMEZ JA, SLATOPOLSKY E: Hyperphosphatemia: its consequences and treatment in chronic renal failure. Am J Kidney Dis 19: 303, 1992.
-
(1992)
Am J Kidney Dis
, vol.19
, pp. 303
-
-
Delmez, J.A.1
Slatopolsky, E.2
-
12
-
-
0030891508
-
Clinical spectrum of chronic metabolic acidosis: Homeostatic mechanisms produce significant morbidity
-
ALPERN RJ, SAKHAEE K: Clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 29: 291, 1997.
-
(1997)
Am J Kidney Dis
, vol.29
, pp. 291
-
-
Alpern, R.J.1
Sakhaee, K.2
-
13
-
-
0037228105
-
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
-
CORESH J, ASTOR BC, GREENE T, ET AL: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1, 2003.
-
(2003)
Am J Kidney Dis
, vol.41
, pp. 1
-
-
Coresh, J.1
Astor, B.C.2
Greene, T.3
-
14
-
-
0032572915
-
Erythropoietin for end-stage renal disease
-
ADAMSON JW, ESCHBACH JW: Erythropoietin for end-stage renal disease. N Engl J Med 339: 625, 1998.
-
(1998)
N Engl J Med
, vol.339
, pp. 625
-
-
Adamson, J.W.1
Eschbach, J.W.2
-
15
-
-
0028348766
-
Hemostasis in renal disease: Pathophysiology and management
-
EBERST ME, BERKOWITZ LR: Hemostasis in renal disease: pathophysiology and management. Am J Med 96: 168, 1994.
-
(1994)
Am J Med
, vol.96
, pp. 168
-
-
Eberst, M.E.1
Berkowitz, L.R.2
-
16
-
-
0034286103
-
Effectively targeting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: Rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors
-
WEINBERG MS, WEINBERG AJ, ZAPPE DH: Effectively targeting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors. J Renin Angiotensin Aldosterone Syst 1: 217, 2000.
-
(2000)
J Renin Angiotensin Aldosterone Syst
, vol.1
, pp. 217
-
-
Weinberg, M.S.1
Weinberg, A.J.2
Zappe, D.H.3
-
17
-
-
0000296833
-
The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
-
WEINBERG MS, WEINBERG AJ, CORD R, ET AL: The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion. J Renin Angiotensin Aldosterone Syst 2: 196, 2001.
-
(2001)
J Renin Angiotensin Aldosterone Syst
, vol.2
, pp. 196
-
-
Weinberg, M.S.1
Weinberg, A.J.2
Cord, R.3
-
18
-
-
0034691822
-
Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
-
TEPEL M, VAN DER GIET M, SCHWARZFELD C, ET AL: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343: 180, 2000.
-
(2000)
N Engl J Med
, vol.343
, pp. 180
-
-
Tepel, M.1
Van Der Giet, M.2
Schwarzfeld, C.3
|